Chemoinformaics analysis of 3,5-bis (1,1-dimethylethyl)-
| Molecular Weight | 641.142 | nRot | 9 |
| Heavy Atom Molecular Weight | 572.598 | nRig | 23 |
| Exact Molecular Weight | 640.471 | nRing | 4 |
| Solubility: LogS | -7.504 | nHRing | 0 |
| Solubility: LogP | 8.343 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 112 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 68 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 39 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 123.938 |
| nHD | 1 | BPOL | 102.57 |
| QED | 0.201 |
| Synth | 5.102 |
| Natural Product Likeliness | 1.542 |
| NR-PPAR-gamma | 0.054 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.53 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.9 |
| MDCK | 0.00000381 |
| BBB | 0.005 |
| PPB | 1.05156 |
| VDSS | 3.491 |
| FU | 0.00379499 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.826 |
| CYP2c19-inh | 0.39 |
| CYP2c19-sub | 0.97 |
| CYP2c9-inh | 0.111 |
| CYP2c9-sub | 0.316 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.782 |
| CYP3a4-inh | 0.503 |
| CYP3a4-sub | 0.911 |
| CL | 1.783 |
| T12 | 0.023 |
| hERG | 0.013 |
| Ames | 0.033 |
| ROA | 0.523 |
| SkinSen | 0.073 |
| Carcinogencity | 0.019 |
| EI | 0.015 |
| Respiratory | 0.921 |
| NR-Aromatase | 0.573 |
| Antiviral | No |
| Prediction | 0.510041 |